Skip to main content

Blood Sugar

Why it’s a big deal for the closed loop and pump fields, when it might be available, and how Tidepool is working with the FDA and companies to make it happen
The latest on Dexcom’s work with Verily to make a more simple and accessible CGM; also, the “Pro Q” professional CGM and insulin dosing advice for people on multiple...
The diaTribe team was on the ground at the 2019 ADA 79th Scientific Sessions to share several of the greatest highlights from the conference!
The first trial, now recruiting 50 people, is an observational study of insulin requirements and glucose levels using the Dexcom G6 CGM in type 1 pregnancy.
A recent study found 38% of those with type 1 diagnosed after age 30 were not initially given insulin; learn ways of differentiating between type 1 and type 2 at...
Control-IQ hybrid closed loop coming in summer 2019; paired app coming soon to the US; plans for the t:sport “patch” pump; and t:slim X2 pump launched outside the US
AgaMatrix blood glucose meters and strips by Amazon could make ordering diabetes supplies more convenient and cheaper
Our readers have spoken! See ten of the most popular diaTribe articles.
The VALyou program, designed to help people paying full-price for insulin not eligible for other patient assistance programs, now includes basal insulin Toujeo and rapid...
The study aims to enroll about 1,800 adults with type 2 diabetes at increased risk of heart disease
A huge milestone that makes Forxiga the first pill for people with type 1 diabetes in Europe
Google’s health arm Verily/Alcon has announced that its project to develop a glucose-sensing contact lens has been put on hold
Tubeless Omnipod will communicate directly with Tidepool Loop app. Insulet’s own Horizon hybrid closed loop expected to launch in second-half of 2020
A currently recruiting study to find out how blood sugar changes during exercise in people with type 1 diabetes
The automated insulin delivery system with Dexcom’s G6 aims to launch in the US by the end of the year for those ages 14+; first system with auto boluses and no...
A currently-recruiting trial is comparing how two types of basal insulin – Toujeo and Tresiba – impact blood sugar levels in adults, using continuous glucose monitoring
Includes one year of unlimited coaching in the One Drop app
FDA approves WellDoc’s BlueStar app (24/7 diabetes management coaching and support) for use in type 1 diabetes. BlueStar insights also now incorporate data from Dexcom...
Control-IQ Hybrid Closed Loop on track to launch in the US by the end of 2019 for those ages 14 and older; first system with automatic correction boluses and no...
A new premixed, liquid glucagon coming in October in a prefilled syringe and in 2020 as an auto-injector. The second stable glucagon approved this year